These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21871134)

  • 1. Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice.
    Yang Y; Jalal FY; Thompson JF; Walker EJ; Candelario-Jalil E; Li L; Reichard RR; Ben C; Sang QX; Cunningham LA; Rosenberg GA
    J Neuroinflammation; 2011 Aug; 8():108. PubMed ID: 21871134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
    Walker EJ; Rosenberg GA
    Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue inhibitor of metalloproteinase-3 is associated with neuronal death in reperfusion injury.
    Wallace JA; Alexander S; Estrada EY; Hines C; Cunningham LA; Rosenberg GA
    J Cereb Blood Flow Metab; 2002 Nov; 22(11):1303-10. PubMed ID: 12439287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
    Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia.
    Svedin P; Hagberg H; Sävman K; Zhu C; Mallard C
    J Neurosci; 2007 Feb; 27(7):1511-8. PubMed ID: 17301159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin loss associated with neuroinflammation in hypertensive rats.
    Jalal FY; Yang Y; Thompson J; Lopez AC; Rosenberg GA
    Stroke; 2012 Apr; 43(4):1115-22. PubMed ID: 22363061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
    Grossetete M; Rosenberg GA
    J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNIP3 mediates pre-myelinating oligodendrocyte cell death in hypoxia and ischemia.
    Li C; Guan T; Chen X; Li W; Cai Q; Niu J; Xiao L; Kong J
    J Neurochem; 2013 Nov; 127(3):426-33. PubMed ID: 23692407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of matrix metalloproteinases-3 (TIMP-3) lacks involvement in bacterial collagenase-induced intracerebral hemorrhage in mouse.
    Grossetete M; Rosenberg GA
    Acta Neurochir Suppl; 2008; 105():89-93. PubMed ID: 19066089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes reduces the proliferation and survival of oligodendrocyte progenitor cells in ishchemic white matter lesions.
    Yatomi Y; Tanaka R; Shimada Y; Yamashiro K; Liu M; Mitome-Mishima Y; Miyamoto N; Ueno Y; Urabe T; Hattori N
    Neuroscience; 2015 Mar; 289():214-23. PubMed ID: 25592431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia.
    Wetzel M; Li L; Harms KM; Roitbak T; Ventura PB; Rosenberg GA; Khokha R; Cunningham LA
    Cell Death Differ; 2008 Jan; 15(1):143-51. PubMed ID: 17962815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of GPR37
    McCrary MR; Jiang MQ; Giddens MM; Zhang JY; Owino S; Wei ZZ; Zhong W; Gu X; Xin H; Hall RA; Wei L; Yu SP
    FASEB J; 2019 Oct; 33(10):10680-10691. PubMed ID: 31268736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY; Loss G; Carmody I; Cohen AJ
    Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
    Suofu Y; Clark JF; Broderick JP; Kurosawa Y; Wagner KR; Lu A
    Neuroscience; 2012 Jun; 212():180-9. PubMed ID: 22521821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture alleviates nerve injury after cerebra ischemia in rats through inhibiting cell apoptosis and changing the balance of MMP-9/TIMP-1 expression.
    Ma R; Yuan B; Du J; Wang L; Ma L; Liu S; Shu Q; Sun H
    Neurosci Lett; 2016 Oct; 633():158-164. PubMed ID: 27664868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes.
    Cross AK; Haddock G; Stock CJ; Allan S; Surr J; Bunning RA; Buttle DJ; Woodroofe MN
    Brain Res; 2006 May; 1088(1):19-30. PubMed ID: 16630594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway.
    Romera C; Hurtado O; Botella SH; Lizasoain I; Cárdenas A; Fernández-Tomé P; Leza JC; Lorenzo P; Moro MA
    J Neurosci; 2004 Feb; 24(6):1350-7. PubMed ID: 14960606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion.
    Lu A; Suofu Y; Guan F; Broderick JP; Wagner KR; Clark JF
    Neuroscience; 2013 Dec; 253():361-7. PubMed ID: 24035828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia.
    Mandai K; Matsumoto M; Kitagawa K; Matsushita K; Ohtsuki T; Mabuchi T; Colman DR; Kamada T; Yanagihara T
    Neuroscience; 1997 Apr; 77(3):849-61. PubMed ID: 9070757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.